File Download
 
 
Supplementary

Conference Paper: Telbivudine vs Lamivudine in HBeAg-Positive Patients with CHB: Two-Year Efficacy and Predictors of Response
  • Basic View
  • Metadata View
  • XML View
TitleTelbivudine vs Lamivudine in HBeAg-Positive Patients with CHB: Two-Year Efficacy and Predictors of Response
 
AuthorsLai, CL
Gane, E
Hsu, CW
Chen, YC
Thongsawat, S
Wang, Y
Chen, Y
Naoumov, N
Han, SH
Hwang, SG
Lim, SG
Brown, NA
 
Issue Date2007
 
DC FieldValue
dc.contributor.authorLai, CL
 
dc.contributor.authorGane, E
 
dc.contributor.authorHsu, CW
 
dc.contributor.authorChen, YC
 
dc.contributor.authorThongsawat, S
 
dc.contributor.authorWang, Y
 
dc.contributor.authorChen, Y
 
dc.contributor.authorNaoumov, N
 
dc.contributor.authorHan, SH
 
dc.contributor.authorHwang, SG
 
dc.contributor.authorLim, SG
 
dc.contributor.authorBrown, NA
 
dc.date.accessioned2010-09-25T20:51:17Z
 
dc.date.available2010-09-25T20:51:17Z
 
dc.date.issued2007
 
dc.identifier.hkuros133878
 
dc.identifier.urihttp://hdl.handle.net/10722/102946
 
dc.languageeng
 
dc.relation.ispartofOral Presetnation at the Parallel Oral Session of the HBV Day of the 17th Asian Pacific Association for the Study of the Liver (APASL) Conference on March 28
 
dc.titleTelbivudine vs Lamivudine in HBeAg-Positive Patients with CHB: Two-Year Efficacy and Predictors of Response
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Lai, CL</contributor.author>
<contributor.author>Gane, E</contributor.author>
<contributor.author>Hsu, CW</contributor.author>
<contributor.author>Chen, YC</contributor.author>
<contributor.author>Thongsawat, S</contributor.author>
<contributor.author>Wang, Y</contributor.author>
<contributor.author>Chen, Y</contributor.author>
<contributor.author>Naoumov, N</contributor.author>
<contributor.author>Han, SH</contributor.author>
<contributor.author>Hwang, SG</contributor.author>
<contributor.author>Lim, SG</contributor.author>
<contributor.author>Brown, NA</contributor.author>
<date.accessioned>2010-09-25T20:51:17Z</date.accessioned>
<date.available>2010-09-25T20:51:17Z</date.available>
<date.issued>2007</date.issued>
<identifier.uri>http://hdl.handle.net/10722/102946</identifier.uri>
<language>eng</language>
<relation.ispartof>Oral Presetnation at the Parallel Oral Session of the HBV Day of the 17th Asian Pacific Association for the Study of the Liver (APASL) Conference on March 28</relation.ispartof>
<title>Telbivudine vs Lamivudine in HBeAg-Positive Patients with CHB: Two-Year Efficacy and Predictors of Response</title>
<type>Conference_Paper</type>
<identifier.hkuros>133878</identifier.hkuros>
</item>